Exact claim · Version 1 · Reviewed 2026-07-23
“CJC-1295 can raise GH and IGF-1 in healthy adults.”
A verdict on this wording and scope, not a universal grade for CJC-1295.
01 · Verdict
Supported with scope
Randomized human studies reported sustained hormone increases. This supports a biomarker effect, not a patient benefit.
- Evidence basis
- Human pharmacology
- Scope
- Short-term GH and IGF-1 pharmacodynamic responses in the healthy adults studied.
- Category
- Mechanism and biomarkers
02 · Primary record
Check the attached evidence
01Prolonged GH and IGF-1 stimulation by CJC-1295 in healthy adultsPubMed · Journal of Clinical Endocrinology & Metabolism · Randomized trial · 2006
Supports the scoped claim02Pulsatile GH secretion during continuous stimulation by CJC-1295PubMed · Journal of Clinical Endocrinology & Metabolism · Human pharmacology · 2006
Supports the scoped claim
Supports the scoped claim02Pulsatile GH secretion during continuous stimulation by CJC-1295PubMed · Journal of Clinical Endocrinology & Metabolism · Human pharmacology · 2006
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.